AdjuTec Pharma AS
🇳🇴Norway
A First-in-human Trial to Evaluate Safety, Tolerability, and Pharmacokinetics of APC148 in Healthy Adults
Phase 1
Completed
- Conditions
- Healthy Subjects
- Interventions
- Drug: APC148 and Placebo
- First Posted Date
- 2024-04-11
- Last Posted Date
- 2025-03-12
- Lead Sponsor
- AdjuTec Pharma AS
- Target Recruit Count
- 46
- Registration Number
- NCT06360640
- Locations
- 🇸🇪
Clinical Trial Consultants AB, Uppsala, Sweden
© Copyright 2025. All Rights Reserved by MedPath